MENU
+Compare
IOBCF
Stock ticker: OTC
AS OF
Dec 24 closing price
Price
$14.50
Change
+$1.25 (+9.43%)
Capitalization
419.04M

IOBCF stock forecast, quote, news & analysis

Ion Beam Applications SA develops and manufactures medical devices and software solutions... Show more

IOBCF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IOBCF with price predictions
Dec 24, 2025

IOBCF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IOBCF turned positive on November 25, 2025. Looking at past instances where IOBCF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where IOBCF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 24, 2025. You may want to consider a long position or call options on IOBCF as a result. In of 50 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

IOBCF moved above its 50-day moving average on December 05, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IOBCF crossed bullishly above the 50-day moving average on December 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where IOBCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The 50-day moving average for IOBCF moved below the 200-day moving average on November 18, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IOBCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IOBCF broke above its upper Bollinger Band on December 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.024) is normal, around the industry mean (63.841). P/E Ratio (21.197) is within average values for comparable stocks, (37.253). IOBCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). Dividend Yield (0.020) settles around the average of (0.019) among similar stocks. P/S Ratio (0.619) is also within normal values, averaging (36.935).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IOBCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IOBCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Dividends

IOBCF paid dividends on June 23, 2021

Ion Beam Applications S.A. IOBCF Stock Dividends
А dividend of $0.20 per share was paid with a record date of June 23, 2021, and an ex-dividend date of June 21, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.7B. The market cap for tickers in the group ranges from 1.86K to 217.03B. ABT holds the highest valuation in this group at 217.03B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 14%. IRME experienced the highest price growth at 86%, while FZMD experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 87
Profit Risk Rating: 93
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
IOBCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Chemin du Cyclotron, 3
Phone
+32 10475811
Employees
1817
Web
https://www.iba-worldwide.com